Annovis Bio (ANVS) Change in Account Payables (2019 - 2026)

Annovis Bio has reported Change in Account Payables for 8 years, with the latest figure at $2.7 million in Q1 2026.

• Quarterly Change in Account Payables rose 386.94% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 242.71% YoY) and the FY2025 annual result came in at $284542.0, down 71.91% from the prior year.
• Change in Account Payables advanced to $2.7 million in Q1 2026 per ANVS's latest filing, from $478490.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $2.8 million in Q1 2024 and troughed at -$3.0 million in Q2 2023.
• A 5-year average of $269858.5 and a median of $240923.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables slumped 10873.87% in 2023, then soared 1368.02% in 2024.
• Over 5 years, Change in Account Payables stood at $2.1 million in 2022, then sank by 129.95% to -$633560.0 in 2023, then slumped by 183.07% to -$1.8 million in 2024, then jumped by 126.68% to $478490.0 in 2025, then surged by 461.17% to $2.7 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $2.7 million, $478490.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.